A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

2012 ◽  
Vol 48 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Patrick Schöffski ◽  
Ahmad Awada ◽  
Herlinde Dumez ◽  
Thierry Gil ◽  
Sylvie Bartholomeus ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Kinase Inhibitor ◽  
Solid Tumours ◽  
The Novel ◽  
Dose Escalation Study

scholarly journals A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours

2017 ◽  
Vol 28 ◽  
pp. v128 ◽  
Author(s):  
A. El-Helali ◽  
R. Plummer ◽  
G. Jayson ◽  
V. Coyle ◽  
Y. Drew ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Solid Tumours ◽  
The Novel ◽  
Dose Escalation Study

1246 POSTER A Phase I Dose-escalation Study of EMD 1214063, an Oral Selective C-Met Inhibitor, in Patients With Advanced Solid Tumours

2011 ◽  
Vol 47 ◽  
pp. S158
Author(s):  
G.S. Falchook ◽  
S. Fu ◽  
H.M. Amin ◽  
S.A. Piha-Paul ◽  
D.S. Hong ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Solid Tumours ◽  
Dose Escalation Study ◽  
Met Inhibitor

A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours

2013 ◽  
Vol 25 (6) ◽  
pp. 362-368 ◽  
Author(s):  
Shodeinde A. Coker ◽  
Uday B. Dandamudi ◽  
Andrew P. Beelen ◽  
Nancy A. Crosby ◽  
Jan L. Fisher ◽  
...  
Keyword(s):  
Phase I ◽  
Interferon Alpha ◽  
Dose Escalation ◽  
Solid Tumours ◽  
Dose Escalation Study ◽  
Interferon Alpha 2B
Sign in / Sign up

Export Citation Format

Share Document